Jiachuan Xiong

Dr. Jiachuan Xiong

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2020 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
QZQuanchao Zhang
Quanchao Zhang
YMYingying Ma
Yingying Ma
FLFaying Lin
Faying Lin
JZJinghong Zhao
Jinghong Zhao
JXJiachuan Xiong
Jiachuan Xiong

8 June 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
SGShuiqin Gong
Shuiqin Gong
AZAihong Zhang
Aihong Zhang
MYMengying Yao
Mengying Yao
WXWang Xin
Wang Xin
XGXu Guan
Xu Guan
JZJinghong Zhao
Jinghong Zhao
Ischemic-reperfusion injury (IRI) is a major pathogenic factor in acute kidney injury (AKI), which directly leads to the hypoxic injury of renal tubular epithelial cells (RTECs). Although emerging studies suggest repressor element 1–silencing transcription factor (REST) as a master regulator of gene repression under hypoxia, its role in AKI remains elusive. Here, we found that REST was upregulated in AKI patients, mice, and RTECs, which was positively associated with the degree of kidney injury, while renal tubule–specific knockout of Rest significantly alleviated AKI and its progression to chronic kidney disease (CKD). Subsequent mechanistic studies indicated that suppression of ferroptosis was responsible for REST-knockdown-induced amelioration of hypoxia-reoxygenation injury, during which process Cre-expressing adenovirus–mediated REST downregulation attenuated ferroptosis through upregulating glutamate-cysteine ligase modifier subunit (GCLM) in primary RTECs. Further, REST transcriptionally repressed GCLM expression via directly binding to its promoter region. In conclusion, our findings revealed the involvement of REST, a hypoxia regulatory factor, in AKI-to-CKD transition and identified the ferroptosis-inducing effect of REST, which may serve as a promising therapeutic target for ameliorating AKI and its progression to CKD.

7 August 2023 in Frontiers in Physiology
Verified
Journal Article
Open access
QHQingyu Huo
Qingyu Huo
THTing He
Ting He
JXJiachuan Xiong
Jiachuan Xiong
JZJinghong Zhao
Jinghong Zhao
Background: The Controlled Nutritional Status (CONUT) score, calculated from albumin, total cholesterol, and lymphocyte count, is a useful indicator for immune-nutritional assessment and is associated with the prognosis of various diseases. However, its relationship with renal outcomes, cardiovascular disease (CVD), and all-cause mortality in patients with diabetic kidney disease is unclear.Methods: This retrospective single-center study enrolled 336 patients with biopsy-confirmed diabetic kidney disease from August 2009 to December 2018. The outcomes were progression to end-stage renal disease (ESRD), CVD events, and death. Univariate and multivariate Cox regression analyses were performed to estimate the association between confounding factors and outcomes. The Kaplan-Meier curve was used to compare the outcomes of the patients according to the median CONUT score. The area under the curve (AUC) evaluated with time-dependent receiver operating characteristics was used to test discriminative power of COUNT score.Results: During a median follow-up period of 5.1 years. The Kaplan-Meier analysis showed that patients in the high CONUT group (CONUT score > 3) had a significantly higher incidence of ESRD, CVD events, and all-cause mortality than those in the low CONUT group (CONUT score ≤ 3). The multivariate COX regression analysis indicated that, The CONUT score was an independent predictor of ESRD (hazards ration [HR] = 1.129, 95% confidence interval [CI] 1.037-1.228, p = 0.005), CVD events (HR = 1.159, 95% CI 1.057-1.271, p = 0.002), and all-cause mortality (HR = 1.299, 95% CI 1.143-1.478, p < 0.001).Conclusion: The CONUT score is an independent risk factor for ESRD, CVD events, and overall death in patients with diabetic kidney disease.

14 January 2022 in Frontiers in Endocrinology
Verified
Journal Article
Open access
HLHaiyang Li
Haiyang Li
YSYunzhu Shen
Yunzhu Shen
ZYZhikai Yu
Zhikai Yu
YHYinghui Huang
Yinghui Huang
THTing He
Ting He
JZJinghong Zhao
Jinghong Zhao
Aims: To investigate the potential role of renal arterial resistance index (RI) in the differential diagnosis between diabetic kidney disease (DKD) and non-diabetic kidney disease (NDKD) and establish a better-quantified differential diagnostic model.Materials and Methods: We consecutively reviewed 469 type 2 diabetes patients who underwent renal biopsy in our center. According to the renal biopsy results, eligible patients were classified into the DKD group and the NDKD group. The diagnostic significance of RI was evaluated by receiver operating characteristic (ROC) curve analysis. Logistic regression analysis was used to search for independent risk factors associated with DKD. Then a novel diagnostic model was established using multivariate logistic regression analysis.Results: A total of 332 DKD and 137 NDKD patients were enrolled for analysis. RI was significantly higher in the DKD group compared with those in the NDKD group (0.70 vs. 0.63, p< 0.001). The optimum cutoff value of RI for predicting DKD was 0.66 with sensitivity (69.2%) and specificity (80.9%). Diabetic retinopathy, diabetes duration ≥ 60 months, HbA1c ≥ 7.0(%), RI ≥ 0.66, and body mass index showed statistical significance in the multivariate logistic regression analysis. Then, we constructed a new diagnostic model based on these results. And the validation tests indicated that the new model had good sensitivity (81.5%) and specificity (78.6%).Conclusions: RI has a potential role in discriminating DKD from NDKD. The RI-based predicting model can be helpful for differential diagnosis of DKD and NDKD.

10 September 2022 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
QLQigang Lan
Qigang Lan
CDChanghong Du
Changhong Du
JXJiachuan Xiong
Jiachuan Xiong
YWYiding Wu
Yiding Wu
WLWeinian Liao
Weinian Liao
KYKe Yang
Ke Yang

3 March 2025 in Theranostics
Verified
Journal Article
Open access
PDF file
SWShaobo Wang
Shaobo Wang
BZBo Zhang
Bo Zhang
YWYaqin Wang
Yaqin Wang
QLQigang Lan
Qigang Lan
LLLiangjing Lv
Liangjing Lv
JXJiachuan Xiong
Jiachuan Xiong
Rationale: The irreversible damage of renal fibrosis has been widely recognized as a critical factor in the progression of chronic kidney disease (CKD) to end-stage kidney failure. This necessitates investigation into its precise mechanisms. Dual-specificity phosphatase 1 (DUSP1), a regulator of mitogen-activated protein kinase (MAPK) pathways, is linked to diseases such as cancer and immune disorders, but its role in renal fibrosis is unclear. This study aimed to clarify the role of DUSP1 in renal fibrosis, identify the intrinsic mechanisms involved, and provide a theoretical basis for the clinical translation of a new target for renal fibrosis treatment.